Stockreport

Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration [Yahoo! Finance]

KIRIN HLDGS CO LTD S/ADR  (KNBWY) 
US:NASDAQ Investor Relations: kirinholdings.co.jp/english/ir
PDF Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shif [Read more]